Pyridinaminosulfonyl substituted benzamides as inhibitors of cytochrome p450 3a4 (cyp3a4)

A kind of C3-C11, alkyl technology, application in the field of pyridylaminosulfonyl substituted benzamide used as cytochrome P450 3A4 (CYP3A4) inhibitor

Inactive Publication Date: 2008-10-15
PFIZER PROD INC
View PDF9 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, RTV is associated with clinically significant gastrointestinal and metabolic side effects, including nausea, vomiting, diarrhea, and dyslipidemia

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pyridinaminosulfonyl substituted benzamides as inhibitors of cytochrome p450 3a4 (cyp3a4)
  • Pyridinaminosulfonyl substituted benzamides as inhibitors of cytochrome p450 3a4 (cyp3a4)
  • Pyridinaminosulfonyl substituted benzamides as inhibitors of cytochrome p450 3a4 (cyp3a4)

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

Embodiment A

Embodiment B

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention provides compounds of formula (I), or pharmaceutically acceptable salts or solvates thereof, methods for their preparation, methods for their use, and pharmaceutical formulations comprising them.

Description

Pyridinesulfamoyl-substituted benzamides as cytochrome P450 3A4 (CYP3A4) inhibitors This application is based on 35 U.S.C. § 119(e) requirements of U.S. Application Nos. 60 / 720,151 filed September 23, 2005, 60 / 723,115 filed October 3, 2005, filed October 11, 2005 Priority 60 / 725,469, 60 / 762,256, filed January 25, 2006, and 60 / 821,664, filed August 7, 2006, each of which is incorporated herein by reference in its entirety. Background technique The cytochrome P450 (CYP450) enzyme system is responsible for the biotransformation of drugs from active to inactive metabolites that are easily excreted by the body. In addition, the rapid metabolism of certain drugs by the CYP450 enzyme system can significantly alter their pharmacokinetic (PK) properties and can lead to subtherapeutic plasma levels of these drugs over time. In the field of anti-infective therapy, such as in the treatment of viral infections, such as human immunodeficiency virus (HIV) infection, such subtherapeutic dr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D213/76A61K31/4406A61P39/00
CPCC07D213/76C07D401/12C07D405/12C07D413/12C07D471/10C07D487/08A61P31/18A61P39/00A61P43/00A61K31/4406A61K31/166
Inventor B·D·帕特森S·K·萨卡塔M·D·南布L·B·K·帕特尔J·H·塔特洛克
Owner PFIZER PROD INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap